ABL Will Have Daily Sessions at Our Booth at the GTC Biomarker Summit 2016
San Diego, CA—March 11, 2016 – ABL will be exhibiting at the GTC Biomarker Summit 2016 in San Diego March 21-23. We welcome you to join us at one of our daily sessions to meet ABL’s new Director of Immunobiology, Dr. Andrew Macintyre, and to discuss both our preclinical and clinical service offerings.
Highlighted topics will include:
- ABL’s diverse platforms
- Our upcoming Biomarker screening services
- How we can customize our flow cytometry assays to fit your needs
Sessions will be held at the ABL booth in the exhibit hall during the morning network break Monday – Wednesday. Should you prefer to schedule a one-on-one discussion with ABL’s team then please contact Jayme Tortorici by email or 619.405.4073.
About ABL, Inc.
ABL, Inc. is a global biomedical contract research and manufacturing organization dedicated to advancing vaccines, therapeutics and other biologic products. ABL has extensive experience working with diverse organizations, including the U.S. Government, biopharmaceutical companies and academic entities. Notable contract manufacturing services include process and assay development, cGMP biologics manufacturing of bulk drug substance, cGMP aseptic fill and finish of drug product, and QC analytics in the U.S. and Europe. ABL also maintains U.S. and European immunological and molecular laboratories to support preclinical and GCLP clinical sample processing and testing. ABL is a part of the Institut Mérieux, a group of companies dedicated to developing translational science for better patient care globally.
For more information visit www.ablinc.com or email us.
